PMID: 16533490Mar 15, 2006Paper

Erythromelalgia

Current Treatment Options in Cardiovascular Medicine
Mark D P Davis, Thom Rooke

Abstract

No treatment is consistently effective in the management of patients with erythromelalgia. There is a dearth of adequate studies examining the response of erythromelalgia to treatment. Most recommendations are suggested based on case reports, small case series, and anecdotal reports. The management of erythromelalgia is difficult and frequently involves a multidisciplinary approach. An approach to management of individuals with erythromelalgia includes patient education, learning to avoid episodes, relieving discomfort of the episodes, controlling secondary and underlying factors, and use of drugs used to control erythromelalgia.

References

Aug 20, 1977·Lancet·J L Bada
Apr 1, 1979·The Journal of Pediatrics·S OzsoyluA Gökalp
Jan 1, 1992·Postgraduate Medical Journal·K ChakravartyS Barker
Jan 1, 1991·Journal of the American Academy of Dermatology·D C Calderone, E Finzi
Jan 1, 1990·Stereotactic and Functional Neurosurgery·E I Kandel
May 1, 1985·Journal of the Autonomic Nervous System·M ZoppiU Buoncristiano
Nov 1, 1973·The British Journal of Surgery·J C Postlethwaite
Mar 18, 1968·JAMA : the Journal of the American Medical Association·H Pepper
Jan 1, 1984·European Journal of Pediatrics·S Ozsoylu, T Coşkun
Mar 1, 1995·Annals of Vascular Surgery·P J Sadighi, E J Arbid
Nov 1, 1994·Postgraduate Medical Journal·K A MuhiddinV R Pearce
Oct 1, 1993·Journal of Pain and Symptom Management·P J Graziotti, C R Goucke
Oct 1, 1994·Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS·M MohrJ Hildebrandt
Jun 1, 1993·American Journal of Hematology·J P Drenth, J J Michiels
May 1, 1996·Anesthesia and Analgesia·R L RauckB P Smith
Apr 20, 1996·Journal of the Autonomic Nervous System·R SakakibaraT Hattori
Jan 1, 1996·Dermatology : International Journal for Clinical and Investigative Dermatology·K OngenaeJ M Naeyaert
Apr 1, 1997·Anesthesiology·T McGraw, P Kosek
May 1, 1997·The Annals of Pharmacotherapy·J D StoneD R Allington
Aug 1, 1997·Journal of the American Academy of Dermatology·D Rudikoff, I A Jaffe
Jul 20, 1999·European Journal of Clinical Investigation·R C LittlefordJ J Belch
Dec 22, 1999·Archives of Dermatology·S M KuhnertM D Davis
Mar 21, 2000·Archives of Dermatology·M D DavisT W Rooke
Mar 21, 2000·Archives of Dermatology·C Mørk, K Kvernebo
Mar 25, 2000·The Journal of Investigative Dermatology·C MorkK Kvernebo
Oct 26, 2000·Journal of the American Academy of Dermatology·J S Cohen
Dec 20, 2000·The Journal of Investigative Dermatology·M D DavisP Sandroni
Jan 12, 2001·The Clinical Journal of Pain·S Macres, S Richeimer
Jul 31, 2001·Lancet·R CimazP Careddu
Sep 19, 2001·Regional Anesthesia and Pain Medicine·L J Stricker, C R Green
Jan 16, 2002·Archives of Dermatology·Mark D P Davis, Paola Sandroni
Feb 19, 2002·The Annals of Pharmacotherapy·Jay S Cohen
Mar 21, 2002·The British Journal of Dermatology·A MoiinB Yashar
Mar 21, 2003·Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi·Atsuhiro Sakamoto
Jul 25, 2003·British Journal of Anaesthesia·V Jaitly
Aug 22, 2003·The New England Journal of Medicine·Shigetoshi SanoKunihiko Yoshikawa
May 19, 2004·Archives of Dermatology·David J DiCaudo, Lee A Kelley
Sep 21, 2004·The British Journal of Dermatology·H-S JangK Kwon
Jun 16, 2005·The Journal of Investigative Dermatology·Joost P H DrenthJan B M J Jansen

❮ Previous
Next ❯

Citations

May 5, 2011·Case Reports in Medicine·Elisabeth JohnsonDenniz Zolnoun
Feb 27, 2014·Journal of Medical Case Reports·Samir M Al-Minshawy, Abdel-Azeem M El-Mazary
Nov 27, 2015·Case Reports in Medicine·Rosario RussoAntonio Russo
Jan 5, 2018·VASA. Zeitschrift für Gefässkrankheiten·Peter Franz Klein-WeigelJutta Gisela Richter
Apr 6, 2007·Nature Clinical Practice. Neurology·Steven P NovellaStephen G Waxman
Oct 29, 2011·Vascular Medicine·Nedaa SkeikRandal C Richardson
Dec 14, 2011·Journal of Child Neurology·Shadé MoodyMary Kay Koenig
Jul 19, 2013·The Korean Journal of Pain·Byoung Chan KangJoung Goo Cho
Dec 29, 2020·The Journal of Biological Chemistry·Clara M KerthJannis E Meents

❮ Previous
Next ❯

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Korean Journal of Pain
Yoo Jin BangYoung Hoon Park
Pain Medicine : the Official Journal of the American Academy of Pain Medicine
Charles J Buttaci
Current Treatment Options in Cardiovascular Medicine
Mark D P Davis, Thom Rooke
© 2021 Meta ULC. All rights reserved